Sign up to save your podcasts
Or
Share Democratizing Diagnostic Testing for Preventable Diseases w/MainzBiomed CEO Guido Baechler
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Democratizing Diagnostic Testing for Preventable Diseases w/MainzBiomed CEO Guido Baechler
Guido Baechler is CEO and Director at Mainz Biomed (NASDAQ: MYNZ) a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection test for colorectal cancer.
Guido has 30 years of global experience leading public & private life sciences companies having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management.
Learn more @MainzBiomed
View all episodes
By Dr. Rich GreenhillGuido Baechler is CEO and Director at Mainz Biomed (NASDAQ: MYNZ) a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection test for colorectal cancer.
Guido has 30 years of global experience leading public & private life sciences companies having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management.
Learn more @MainzBiomed